Weight gain after adenotonsillectomy is more common in young children

David F Smith1, Ami R Vikani, James R Benke

  • 1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

Insights

Children undergoing adenotonsillectomy (TA) often gain weight post-surgery. Younger children, specifically those 6 years or younger, are more likely to experience significant weight gain after TA for sleep apnea or tonsillitis.

Area of Science:

  • Pediatric Otolaryngology
  • Pediatric Sleep Medicine
  • Pediatric Endocrinology

Background:

  • Adenotonsillectomy (TA) is a common procedure for pediatric obstructive sleep apnea (OSA) and recurrent tonsillitis (RT).
  • Previous studies indicate a correlation between TA and subsequent weight gain in children.
  • Understanding demographic factors influencing this weight gain is crucial for patient management.

Purpose of the Study:

  • To investigate demographic factors associated with postoperative weight gain in a large cohort of children undergoing TA.
  • To analyze the impact of age, gender, and race on weight changes after adenotonsillectomy.

Main Methods:

  • Retrospective chart review of children who underwent TA between 2008 and 2011 at an urban academic center.
  • Comparison of demographic data, OSA severity, and normalized Body Mass Index (BMI) z-scores pre- and post-surgery.
  • Statistical analysis, including multiple linear regression, to identify predictors of weight gain.

Main Results:

  • Weight data were available for 115 children; 85 underwent surgery for OSA.
  • Overall BMI z-scores increased significantly post-TA (0.98 to 1.21, P = .0009).
  • Younger age (≤ 6 years) was a significant negative predictor of BMI z-score change (P = .015), indicating greater weight gain in younger children.

Conclusions:

  • Consistent with prior research, children experience weight gain following adenotonsillectomy.
  • Younger age is a significant predictor of increased postoperative weight gain.
  • Prospective studies are recommended to further explore the relationship between demographic factors, particularly age, and weight gain after TA.
Abstract

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...